2001 ROSS AVENUE, SUITE 3400, DALLAS, TX
Other Events
Unregistered Sales of Equity Securities
Q2
Q1
FY 2025
Q3
FY 2024
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Form D Notice of Exempt Offering of Securities